Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2005
10/05/2005EP1581242A2 Compositions and methods for modifying toxic effects of proteinaceous compounds
10/05/2005EP1581174A2 Yeast-based vaccines as immunotherapy
10/05/2005EP1581171A2 Antibodies against gpr64 and uses thereof
10/05/2005EP1581119A2 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
10/05/2005EP1581092A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1248654B1 Intra-tumoral administration of il-12 encoding naked nucleic acid molecules
10/05/2005EP1175437B1 Vaccine
10/05/2005EP0914157B1 Anti-tnf antibodies / tnf receptor and methotrexate in the treatment of autoimmune disease
10/05/2005CN1678633A Anti-IGF-I receptor antibody
10/05/2005CN1678630A HCV fusion proteins with modified NS3 domains
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678625A Humanized anti-lymphotoyin beta receptor antibodies
10/05/2005CN1678349A Compositions against chicken coccidiosis
10/05/2005CN1678348A Compositions and methods for therapeutic treatment
10/05/2005CN1678347A Antibodies and uses thereof
10/05/2005CN1678346A Vaccine for respiratory and reproductive system infections in cattle
10/05/2005CN1678345A Multi plasmid system for the production of influenza virus
10/05/2005CN1678344A Human papilloma virus treatment
10/05/2005CN1678343A Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
10/05/2005CN1678338A Method and composition for regulating the activity of regulatory T cells
10/05/2005CN1678188A Nucleic acid compositions for stimulating immune responses
10/05/2005CN1676531A Recombinant immunotoxin based on pseudomonas exotoxin containing (Arg) 9 peptide segment
10/05/2005CN1676124A Antibody chemotherapy-medicine
10/05/2005CN1221569C Cell surface molecule mediating cell adhesion and signal transmission
10/05/2005CN1221568C Composition and methods for detecting and treating acquired immunodeficiency syndrome
10/05/2005CN1221285C Method for preparing genetically engineered nano vaccine for malignant tumour, such as liver cancer, stomach cancer and breast cancer
10/04/2005US6951845 Method for treating allergic lung disease
10/04/2005US6951756 Closure of bacterial ghost
10/04/2005US6951754 Expression vector for use as transformation and gene expression tool in genetic engineering
10/04/2005US6951743 Transgenic cell for use in producing hyaluronic acid
10/04/2005US6951732 Virulence genes, proteins, and their use
10/04/2005US6951717 Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
10/04/2005US6951653 Streptococcal C5a peptidase vaccine
10/04/2005US6951652 Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
10/04/2005US6951651 CTL epitope analogs
10/04/2005US6951650 Antigenic class of avian reoviruses
10/04/2005US6951649 Methods of making neuraminidase-supplemented compositions
10/04/2005US6951648 Variant of LAV viruses
10/04/2005US6951647 T cell binding ligand peptides and method of inducing a cellular immune response
10/04/2005US6951646 recognizing conformation dependent epitopes of HCV glycoprotein E2 that are capable of neutralizing the binding of E2 protein onto susceptible cells
10/04/2005CA2104877C Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
10/02/2005CA2461375A1 Cea binding agents compositions to reverse cea-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof
09/2005
09/29/2005WO2005090986A2 Analysis of saccharide vaccines without interference
09/29/2005WO2005090985A1 Separation of unconjugated and conjugated saccharide by solid phase extraction
09/29/2005WO2005090974A1 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
09/29/2005WO2005090968A1 Tat-based immunomodulatory compositions and methods of their discovery and use
09/29/2005WO2005090584A2 Influenza vaccine based on fowl plague viruses
09/29/2005WO2005090579A1 Modified bouganin proteins, cytotoxins and methods and uses thereof
09/29/2005WO2005090573A2 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
09/29/2005WO2005090569A1 Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005090393A2 Multimeric protein toxins to target cells having multiple identifying characteristics
09/29/2005WO2005090392A1 Tat-based tolerogen compositions and methods of making and using same
09/29/2005WO2005090391A1 Novel tat complexes, and vaccines comprising them
09/29/2005WO2005090390A1 Novel assay for the separation and quantification of hemagglutinin antigens
09/29/2005WO2005090389A2 Isosteric transformation
09/29/2005WO2005089802A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005WO2005089799A1 Cytotoxicity method using effector function of anti-fam3d antibody
09/29/2005WO2005089797A2 Support system in the form of protein-based nanoparticles for the cell-specific enrichment of pharmaceutically active substances
09/29/2005WO2005089796A1 Site-specific chemical modification of hiv gp41-derived peptides
09/29/2005WO2005089795A2 Infectious bursal disease virus antigenic isolates and vaccines
09/29/2005WO2005089794A2 Combination vaccines with low dose of hib conjugate
09/29/2005WO2005089793A1 Method of vaccination against testicular bvdv infection
09/29/2005WO2005089792A1 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof
09/29/2005WO2005089787A1 Use of poly-glu,tyr for treatment of stroke and other disorders
09/29/2005WO2005089762A2 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition
09/29/2005WO2005089712A1 Lyophilization method to improve excipient crystallization
09/29/2005WO2005089503A2 Cd4-igg2 formulations
09/29/2005WO2005089447A2 Streptococcus agalactiae vaccine
09/29/2005WO2005089372A2 Therapeutic synergy of anti-cancer compounds
09/29/2005WO2005089262A2 Novel peanut skin extract as a vaccine adjuvant
09/29/2005WO2005089231A2 Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide
09/29/2005WO2005089164A2 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
09/29/2005WO2005089101A2 Non-pathogenic listeria vaccine vectors and methods of treatment therewith
09/29/2005WO2005079508A3 Method and composition for angiogenesis inhibition
09/29/2005WO2005074460A3 Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods
09/29/2005WO2005067620A3 ANTIBODIES TO MAdCAM
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005WO2005062709A3 Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
09/29/2005WO2005056051A3 Hepatitis b vaccines and compositions
09/29/2005WO2005025509A3 Methods and materials for treating autoimmune diseases and conditions
09/29/2005WO2005023295A3 Naturally processed immunodominant peptides derived from neisseria meningitidis porin a protein and their use
09/29/2005WO2005023205A3 Compositions and methods for yersinia pestis treatment
09/29/2005WO2005007674A3 Anti-human vitronectin antibody and methods for making the same
09/29/2005WO2005003295A3 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds
09/29/2005WO2005000244A3 Methods and compositions for treating rheumatoid arthritis
09/29/2005WO2004108939A8 Bav packaging regions and e1 transcriptional control regions
09/29/2005WO2004101737A3 A novel adjuvant capable of specifically activating the adaptive immune response
09/29/2005WO2004099389A3 Dna vaccines against tumor growth and methods of use thereof
09/29/2005WO2004031365A3 Sulfatases and methods of use thereof
09/29/2005WO2004014314A3 Methods and compositions concerning poxviruses and cancer
09/29/2005WO2003076469A9 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/29/2005US20050216960 Using tumor necrosis factor related apoptosis inducing ligand receptor (TRAIL-R) to identify modulators of dendritic cell immune response
09/29/2005US20050215770 Antibodies against Nogo receptor
09/29/2005US20050215767 Fcgamma riib specific antibodies and methods of use thereof
09/29/2005US20050215766 Allergen from mugwort pollen
09/29/2005US20050215565 Using sulfonamides such as N-[N-(3-pyridinesulfonyl)-L-3,3-dimethyl-4-thiaprolyl]-O-[1-methylpiperazin-4-ylcarbonyl]-L-tyrosine isopropyl ester optionally with immunoglobulins, steroids, antiinflammatory agents
09/29/2005US20050215501 Methods and products for enhancing epitope spreading
09/29/2005US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens
1 ... 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 ... 1823